About the Event

MTPConnect is delivering the $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease, supported by the MRFF. The TTRA is providing a new integrated research program to improve the prevention, diagnosis, treatment and management of diabetes and cardiovascular disease (D&CVD) in Australia.

Applications for Round 3 Research Projects funding opportunity open 30 January 2023, to support eligible organisations in developing or progressing innovative preventative, diagnostic, therapeutic and disease management products, services and/or models of care to benefit the health and wellbeing of Aboriginal and Torres Strait Islander people living with D&CVD.

Funding guidelines and application information can be found on the TTRA webpage.

Submissions close at 16:00 AEST on Friday 28 April 2023.

During the Information Session, you will hear from MTPConnect's TTRA team and the TTRA Partners.

Register to attend the TTRA Research Projects Information Session today to find out more about this Indigenous-specific funding round, the Priority Areas and the application process.

In anticipation of the round, MTPConnect is also hosting a webinar series highlighting key elements of Aboriginal and Torres Strait Islander health research that potential applicants should consider when building their projects and teams. Find the first webinar in the series – ‘Principles of Aboriginal and Torres Strait Islander health research and engaging meaningfully with community’ on the MTPConnect website.

AUDIENCE: D&CVD researchers, Aboriginal and Torres Strait Islander researchers, research institutes, universities, SMEs, industry, clinicians, digital health, medical device, therapeutics, health service innovations.

Duration: 1 hour 15 mins